Randomized comparison of etoposide-cisplatin vs etoposide-carboplatin and irradiation in small cell lung cancer (SCLC): Evaluation of long term survival

被引：0
|
作者：
Samantas, E [1 ]
Milonakis, M [1 ]
Klouvas, G [1 ]
Panoussaki, A [1 ]
Agelidou, M [1 ]
Palamidas, F [1 ]
Boleti, E [1 ]
Kosmas, E [1 ]
Papadakis, E [1 ]
Kiamouris, N [1 ]
Vardoulakis, T [1 ]
Kosmidis, P [1 ]
Pavlidis, N [1 ]
Foutzilas, G [1 ]
Skarios, DV [1 ]
机构：
[1] HELLEN COOPERAT ONCOL GRP,ATHENS,GREECE
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1078 / 1078
页数：2
相关论文
共 50 条
  • [1] RANDOMIZED COMPARISON OF ETOPOSIDE-CISPLATIN VS ETOPOSIDE-CARBOPLATIN AND IRRADIATION IN SMALL-CELL LUNG-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
    SKARLOS, DV
    SAMANTAS, E
    KOSMIDIS, P
    FOUNTZILAS, G
    ANGELIDOU, M
    PALAMIDAS, P
    MYLONAKIS, N
    PROVATA, A
    PAPADAKIS, E
    KLOUVAS, G
    THEOCHARIS, D
    PANOUSAKI, E
    BOLETI, E
    SPHAKIANOUDIS, G
    PAVLIDIS, N
    [J]. ANNALS OF ONCOLOGY, 1994, 5 (07) : 601 - 607
  • [2] SURVIVAL OUTCOMES OF SMALL CELL LUNG CANCER PATIENTS (SCLC) TREATED WITH CISPLATIN-ETOPOSIDE (EP) VS. CARBOPLATIN-ETOPOSIDE (EC) IN BRITISH COLUMBIA (BC)
    Jiang, Shi Yuan
    Schellenberg, Devin
    Karam, Irene
    Lee, Christopher W.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1351 - S1352
  • [3] CISPLATIN/ETOPOSIDE VERSUS CARBOPLATIN/ETOPOSIDE CHEMOTHERAPY AND IRRADIATION IN SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY
    KOSMIDIS, PA
    SAMANTAS, E
    FOUNTZILAS, G
    PAVLIDIS, N
    APOSTOLOPOULOU, F
    SKARLOS, D
    [J]. SEMINARS IN ONCOLOGY, 1994, 21 (03) : 23 - 30
  • [4] Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
    Li, Yue-Ya
    Zhou, Chan
    Yang, Deng-Xia
    Wang, Jing
    Liu, Zhu-Jun
    Wang, Xin-Yue
    Li, Kai
    [J]. CANCER BIOLOGY & MEDICINE, 2015, 12 (02) : 117 - 125
  • [5] Chemotherapy in small-cell lung cancer (SCLC):: A randomized trial of high-dose epirubicin-cisplatin (HDEP) versus etoposide-cisplatin (EP).
    Gómez-Codina, J
    Artal, A
    González-Larriba, JL
    Campbell, J
    Barneto, I
    Carrato, A
    Isla, D
    Camps, C
    García-Girón, C
    Font, A
    Meana, A
    Lomas, M
    Vadell, C
    Arrivi, A
    Alonso, C
    Maestu, I
    Rosell, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S63 - S63
  • [6] Ifosfamide, etoposide, Carboplatin and cisplatin in the treatment of small cell lung cancer
    Mahjoubi, R
    Llory, JF
    Brugiere, O
    Vannetzel, JM
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 105 - 105
  • [7] CISPLATINUM PLUS ETOPOSIDE (A) VS CARBOPLATINUM PLUS ETOPOSIDE (B) PLUS IRRADIATION IN SMALL-CELL LUNG-CANCER (SCLC)
    SAMANTAS, E
    KOSMIDIS, P
    PAVLIDIS, N
    KLOUVAS, G
    BOLETI, A
    YIOTI, A
    KOSMAS, E
    BEER, M
    KARPASITIS, N
    SKARLOS, DV
    FOUNTZILAS, G
    MYLONAKIS, N
    MAKRANTONAKIS, P
    AGELIDOU, M
    BARLAS, K
    PAPADAKIS, E
    PANOUSAKI, A
    [J]. JOURNAL OF CHEMOTHERAPY, 1993, 5 : 700 - 701
  • [8] Outcomes of Small Cell Lung Cancer Patients Treated With Cisplatin-Etoposide Versus Carboplatin-Etoposide
    Karam, Irene
    Jiang, Shi Yuan
    Khaira, Mandip
    Lee, Christopher W.
    Schellenberg, Devin
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (01): : 51 - 54
  • [9] A pharmacoeconomic evaluation of cisplatin in combination with either etoposide or etoposide phosphate in small cell lung cancer
    Doyle, JJ
    Dezii, CM
    Sadana, A
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (06) : 51 - 60
  • [10] CARBOPLATIN (JM8), ETOPOSIDE (VP16) AND THORACIC IRRADIATION FOR SMALL CELL LUNG-CANCER (SCLC) - AN EVALUATION OF LUNG TOXICITY
    GLAHOLM, J
    REPETTO, L
    YARNOLD, JR
    SMITH, IE
    ASHLEY, SE
    MAGRINI, S
    CHERRYMAN, G
    [J]. RADIOTHERAPY AND ONCOLOGY, 1988, 12 (01) : 31 - 37
12345